CareValidate expanded its HRT offering for telehealth companies, combining hormone therapy with provider access, pharmacy ...

CMS has introduced uncertainty about whether Medicare will participate in that modernization or preserve the old system under a different name. The consequences extend far beyond billing ...

Novartis has made kidney disorders an area of focus, and it’s now adding a new drug prospect through a deal to acquire Regulus Therapeutics, a biotech with a drug ready for pivotal testing in a rare ...

Fractyl Health reported positive six-month trial results from an investigation of its Revita procedure last week, but shares ...

Gilead Sciences is getting global rights to an experimental PepStar Therapeutics oral peptide designed to inhibit the IL-23 ...

The MATCH IT Act aims to reduce patient matching errors. But a model used by vital records systems could provide a better ...

MedTech Conference panelists cited inflammation research, listening to women, clinical trial representation and investment as ...

OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved ...

HealthTap launched a virtual care program to support sleep equipment suppliers and patients using PAP therapy.

In addition to a packed conference agenda and tours of the Pegasus Park healthcare and life science innovation hub in Dallas, ...

Rick Abramson, a radiologist by training and the director of FDA's Digital Health Center of Excellence said, "We ended up ...

The GSK cancer immunotherapy Jemperli is now approved for treating advanced cases of rectal cancer harboring a particular ...